Helpdesk

Sales contact

Home > Neuroscience

Neuroscience

White Paper

Turning endpoint noise into reliable CNS trial data

Go back CNS Most CNS trials don't fail because the therapy doesn't work. They fail because assessment variability buries the signal. This white paper explores how linguistic and cultural adaptation,...

Webinar

Better Raters, Smarter eCOA, Stronger Data

Neuroscience Rater training

Go back ● Replay Tackling variability in CNS clinical trials: Enhancing data reliability in neuroscience studies through structured rater training...

Article

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical Officer at Kayentis

Neuroscience Rater training

Endpoint reliability is a critical factor in the success of clinical trials, particularly those relying on clinician‑reported outcomes. Estelle Haenel,...

Press Release

Kayentis and RWS join forces to improve data confidence in neuroscience clinical trials

Interoperability Neuroscience Rater training

Combining best-in-class electronic Clinical Outcome Assessment (eCOA) technology with expert rater training to reduce variability and strengthen clinical outcomes data...

Subscribe to our newsletter

How Kayentis Delivered eCOA Go-Live in Just 5 Weeks for...

Turning endpoint noise into reliable CNS trial data

Kayentis publishes its first ESG report, strengthening its commitment to...

Kayentis launches interactive eConsent solution to simplify and improve patient...

Better Raters, Smarter eCOA, Stronger Data

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.